第一太平(00142.HK): KKR投資於METRO PACIFIC INVESTMENTS CORPORATION醫院業務
格隆匯10月15日丨第一太平(00142.HK)公佈,於10月14日,MPHHI及MPIC(聯屬公司)分別與KKR成立的投資公司(作為投資者)訂立股份認購協議及可換股債券認購協議。股份認購協議及可換股債券認購協議共同與投資者投資於MPIC的醫院及醫療保健業務。
股份認購協議列明,由投資者認購52億披索(約1.002億美元或7.817億港元)的新MPHHI普通股,相當於MPHHI總面值約6.25%。
可換股債券認講協議則列明,由投資者認購301億披索(約5.801億美元或45億港元)的強制可換股債券,將於完成時由MPIC按認購協議發行,可交換成MPIC所持有的239,932,962股MPHHI股份,相當於根據股份認購協議完成認購新MPHHI股份時的MPHHI經擴大已發行普通股本的36.29%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.